Advertisement

H-2 Antigens pp 641-650 | Cite as

Altered MHC Class I Genes Can Encode Immunogenic Antigens that Cause Tumor Rejection

  • Hans J. Stauss
  • Mary Ann Fink
  • Barbara Starr
  • Hans Schreiber
Part of the NATO ASI Series book series (NSSA, volume 144)

Abstract

The C3H UV—induced skin tumor 1591 is highly immunogenic and is rejected when transplanted into immunocompetent syngeneic C3H mice. We have isolated three MHC class I genes from a genomic tumor library and we show that these genes encode novel class I antigens expressed in 1591 tumor cells but not in normal C3H cells. All three genes account for a restriction fragment length polymorphism in the tumor DNA relative to normal C3H DNA, indicating that the genes were not preexistant in the C3H genome but arose by mutation or recombination. We show that one of the tumor class I genes encodes a highly immunogenic class I antigen which is a target antigen for tumor rejection in immunocompetent hosts.

Keywords

Tumor Rejection Progressor Variant Restriction Fragment Length Polymorphism Immunogenic Antigen Aminoglycoside Phosphotransferase 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Alter, B. J., Schendel, D. J., Bach, M. L., Bach, F. H., and Stimpfling, J. H., 1973, Cell—mediated lympholysis. Importance of serologically defined H-2 regions., J. Exp. Med., 137: 1303.PubMedCentralPubMedCrossRefGoogle Scholar
  2. Baily, D. W., 1982, How pure are inbred strains of mice., Immunol. Today, 3: 210.CrossRefGoogle Scholar
  3. Cepko, C. L., Roberts, B. E., and Mulligan, R. C., 1984, Construction and applications of a highly transmissible retrovirus shuttle vector., Cell, 37: 1053.PubMedCrossRefGoogle Scholar
  4. Doherty, P. C., and Zinkernagel, R. M., 1975, H-2 compatibility is required for T cell—mediated lysis of target cells infected with lymphocytic choriomeningitis virus., J. Exp. Med., 141: 502.PubMedCrossRefGoogle Scholar
  5. Doherty, P. C., Knowles, B. B., and Wettstein, P. J., 1984, Immunological surveillance of tumors in the context of major histocompatibility complex restriction of T cell function., Adv. Cancer Res., 42: 1.PubMedGoogle Scholar
  6. Fisher, M. S., and Kripke, M. L., 1978, Systemic alteration induced in mice by ultraviolet light irradiation and its relationship to ultraviolet carcinogenesis., Proc. Natl. Acad. Sci. USA, 74: 1688.CrossRefGoogle Scholar
  7. Frischauf, A., Lehrach, H., Poustka, A., and Murray, N., 1983, Lambda replacement vectors carrying polylinker sequences., J. Mole. Bio., 170: 827.CrossRefGoogle Scholar
  8. Klein, G., Sjogren, H. 0., Klein, E., and Hellstrom, K. E., 1960, Demonstration of resistance against methylcholanthrene—induced sarcomas in the primary autochthonous host., Cancer Res., 20: 1561.PubMedGoogle Scholar
  9. Kripke, M. L., 1981, Immunologic mechanisms in UV radiation carcinogenesis., Adv. Cancer Res., 34: 69.PubMedGoogle Scholar
  10. McMillan, M., Lewis, K. D., and Rovner, D. M., 1985, Molecular characterization of novel H-2 class I molecules expressed by a C3H UV—induced fibrosarcoma., Proc. Natl. Acad. Sci. USA, 82: 5485.PubMedCrossRefGoogle Scholar
  11. Ozato, K., Hansen, T. H., and Sachs, D., 1980, Monoclonal antibodies to mouse MHC antigens., J. Immunol., 125: 2473.PubMedGoogle Scholar
  12. Parmiani, G., Carbone, G., Invernizzi, G., Pierotti, M. A., Sensi, M. L., Rogers, M. J., and Appela, E., 1979, Alien histocompatibility antigens on tumor cells., Immunogenetics, 9: 1.CrossRefGoogle Scholar
  13. Philipps, C., McMillan, M., Flood, P. M., Murphy, D. B., Forman, J., Lancki, D., Womack, J. E., Goodenow, R. S., and Schreiber, H., 1985, Identification of a unique tumor—specific antigen as a novel class I major histocompatibility molecule., Proc. Natl. Acad. Sci. USA, 82: 5140.PubMedCrossRefGoogle Scholar
  14. Philipps, C., Stauss, H. J., Wortzel, R. D., and Schreiber, H., 1986, A novel MHC class I molecule as tumor—specific antigen: correlation between the antibody—defined and the CTL—defined target structure., J. Immunogenet., (Oxf.), in press.Google Scholar
  15. Prehn, R. T., and Main, J. M., 1957, Immunity to methlcholanthreneinduced sarcomas., J. Natl. Cancer Inst., 18: 769.PubMedGoogle Scholar
  16. Stauss, H. J., Linsk, R., Fischer, A., Watts, S., Banasiak, D., Haberman, A., Clark, I., Forman, J., McMillan, M., Schreiber, H., and Goodenow, R., 1986a, Isolation of the MHC genes encoding the tumor—specific class I antigens expressed on a murine fibrosarcoma., J. Inmunogenet., 13: 101.CrossRefGoogle Scholar
  17. Stauss, H. J., Van Waes, C., Fink, M. A., Starr, B., and Schreiber, H., 1986b, Identification of a unique tumor antigen as rejection antigen by molecular cloning and gene transfer., J. Exp. Med., 164: 1516.PubMedCrossRefGoogle Scholar
  18. Steinmetz, M., Frelinger, J. G., Fisher, D., Hunkapiller, T., Pereira, D., Weissman, S. W., Uehara, H., Nathenson, S. and Hood, L., 1981, Three cDNA clones encoding mouse transplantation antigens: homology to immunoglobulin genes., Cell, 24: 125.PubMedCrossRefGoogle Scholar
  19. Urban, J. L., Burton, R. C., Hôlland, J. M., Kripke, M., and Schreiber, H., 1982, Mechanisms of syngeneic.tumor rejection. Susceptibility of host—selected progressor variants to various immunological effector cells., J. Exp. Med., 155: 557.PubMedCrossRefGoogle Scholar
  20. Uyttenhove, C., Maryanski, J., and Boon, T., 1983, Escape of mouse mastocytoma P815 after nearly complete rejection is due to antigen—loss variants rather than immunosuppression., J. Exp. Med., 157: 1040.PubMedCrossRefGoogle Scholar
  21. Wortzel, R. D., Philipps, C., and Schreiber, H., 1983, Multiple tumor—specific antigens expressed on a single tumor cell., Nature, 304: 165.PubMedCrossRefGoogle Scholar
  22. Wortzel, R. D., Urban, J. L., and Schreiber, H., 1984, Ma iT gnant growth in the normal host after variant selection in vitro with cytolytic T cell lines., Proc. Natl. Acad. Sci. USA, 81: 2186.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1987

Authors and Affiliations

  • Hans J. Stauss
    • 1
  • Mary Ann Fink
    • 1
  • Barbara Starr
    • 1
  • Hans Schreiber
    • 1
  1. 1.Department of PathologyThe University of ChicagoChicagoUSA

Personalised recommendations